학술논문
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
Document Type
Article
Author
Chataway, J.; De Angelis, F.; Plantone, D.; Doshi, A.; John, N.; Stutters, J.; MacManus, D.; Prados Carrasco, F.; Barkhof, F.; Braisher, M.; Gandini Wheeler-Kingshott, C.A.; Connick, P.; Chandran, S.; Parker, R.A.; Ross, M.; Cranswick, G.; Weir, C.J.; Ourselin, S.; Pavitt, S.H.; Giovannoni, G.; Hawkins, C.; Sharrack, B.; Bastow, R.; Stallard, N.; Williams, T.; Beyene, T.; Bassan, V.; Zapata, A.; Lyle, D.; Cameron, J.; Mollison, D.; Colville, S.; Dhillon, B.; Parker, R.A.; Gnanapavan, S.; Nicholas, R.; Rashid, W.; Aram, J.; Ford, H.; Overell, J.; Young, C.; Arndt, H.; Duddy, M.; Guadagno, J.; Evangelou, N.; Craner, M.; Palace, J.; Hobart, J.; Paling, D.; Kalra, S.; McLean, B.
Source
In: The Lancet Neurology . (The Lancet Neurology, 1 March 2020, 19(3):214-225)
Subject
Language
English
ISSN
14744465
14744422
14744422